A new ricinuleid species, Cryptocellus chimaera sp. nov., is described based on a male specimen from Northwest Ecuador (Esmeraldas, Reserva Ecológica Mache-Chindul, Estación Biológica Bilsa). This species is unique among all Cryptocellus in having very large longitudinal carapacial translucent areas together with a markedly incrassate femur of leg II. Representing only the second species of the order described from Ecuador, C. chimaera sp. nov. is assigned to the magnus species-group of Cryptocellus Westwood, 1874. Cryptocellus chimaera sp. nov. is remarkable, for its morphology resembles that of Cryptocellus magnus Ewing, 1929, especially with regard to the male copulatory apparatus, although both resemble Pseudocellus Platnick, 1980, due to the presence of diffuse longitudinal carapacial translucent areas. Along with the new species description, a comparative diagnosis and supplementary images are provided for C. magnus. Based on direct observations of some species belonging to the five species-groups of Cryptocellus, we discuss on the occurrence of different morphologies of carapacial translucent areas within the genus. We deem it important to continue the survey of morphological characters, especially within Cryptocellus, in order to increase our understanding of the species-groups and to unravel their relationships.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.11646/zootaxa.4107.3.2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
In silico analysis of -derived peptides and plasmid construction for recombinant anti-aging therapies.
Narra J
December 2024
Department of Medicine, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia.
Skin aging is one of the degenerative processes influenced by tyrosinase, elastase, collagenase, hyaluronidase, and matrix metalloproteinase-9 (MMP9) activity. One promising avenue for discovering antiaging therapeutics is the peptides from the spine. The aim of this study was to explore the potential of peptides from spine as a multitarget inhibitor for recombinant antiaging therapies through in silico approaches.
View Article and Find Full Text PDFET-PROTACs: modeling ternary complex interactions using cross-modal learning and ternary attention for accurate PROTAC-induced degradation prediction.
Brief Bioinform
November 2024
Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410003, China.
Motivation: Accurately predicting the degradation capabilities of proteolysis-targeting chimeras (PROTACs) for given target proteins and E3 ligases is important for PROTAC design. The distinctive ternary structure of PROTACs presents a challenge to traditional drug-target interaction prediction methods, necessitating more innovative approaches. While current state-of-the-art (SOTA) methods using graph neural networks (GNNs) can discern the molecular structure of PROTACs and proteins, thus enabling the efficient prediction of PROTACs' degradation capabilities, they rely heavily on limited crystal structure data of the POI-PROTAC-E3 ternary complex.
View Article and Find Full Text PDFExploring Orodispersible Films Containing the Proteolysis Targeting Chimera ARV-110 in Hot Melt Extrusion and Solvent Casting Using Polyvinyl Alcohol.
Pharmaceutics
November 2024
Merck Life Science KGaA, 64293 Darmstadt, Germany.
Background/objectives: This project aims to provide valuable insights into the formulation of orodispersible films (ODFs) for the delivery of PROTAC ARV-110. The primary objective of this drug delivery formulation is to enhance the solubility of PROTAC ARV-110, which faces significant challenges due to the low solubility of this active pharmaceutical ingredient, as it belongs to a molecular class that is considered to exceed the "Rule of Five".
Methods: We employed the concept of developing a rapidly disintegrating ODF to enhance the solubility of PROTAC ARV-110, utilizing polyvinyl alcohol as the polymer of choice.
The molecular basis of pH sensing by the human fungal pathogen TOK potassium channel.
iScience
December 2024
Bioelectricity Laboratory, Department of Physiology and Biophysics, School of Medicine, University of California, Irvine, Irvine, CA 92697, USA.
Two-pore domain, outwardly rectifying potassium (TOK) channels are exclusively expressed in fungi. Human fungal pathogen TOK channels are potential antifungal targets, but TOK channel modulation in general is poorly understood. Here, we discovered that TOK (CaTOK) is regulated by extracellular pH, in contrast to TOK channels from other fungal species tested.
View Article and Find Full Text PDFAptamer Proteolysis-Targeting Chimeras (PROTACs): A Novel Strategy to Combat Drug Resistance in Estrogen Receptor α-Positive Breast Cancer.
ACS Pharmacol Transl Sci
December 2024
State Key Laboratory of Chemical Oncogenomics, Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
Breast cancer with positive expression of estrogen receptor α (ERα+) accounts for 70% of breast cancer cases, whose predominant treatment is currently endocrine therapy. The main strategy of endocrine therapy for ERα+ breast cancer is to inhibit the ERα signaling pathway and downregulate ERα levels, which often results in mutations in the ligand-binding domain (LBD) of ERα, leading to significant resistance to subsequent treatment in patients. To combat drug resistance, we first proposed a novel aptamer PROTAC strategy through specifically targeted degradation of ERα via targeting the DNA-binding domain (DBD) of ERα.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!